New type 2 diabetes treatment could mean an end to insulin shots
Oct 14, 2024 · 86% of type 2 diabetics treated with a new procedure no longer needed insulin throughout the two-year-long study they participated in. That procedure could be a real game changer for nearly...
Diabetes Breakthrough: New Treatment Eliminates Insulin
Oct 17, 2024 · A new treatment combining ReCET and semaglutide could eliminate the need for insulin in type 2 diabetes, with 86% of participants in a study no longer requiring insulin therapy. The treatment was safe and well-tolerated, and further trials are planned to confirm these results.
The Newest Diabetes Drugs on the Market - Verywell Health
Nov 1, 2023 · Many new medication options have been developed for type 1 or type 2 diabetes in recent years. The newest treatment options include medications taken by mouth, synthetic insulins, as well as injectables.
Use of New Diabetes Medicines | Diabetes | CDC - Centers for …
May 15, 2024 · In 2022, the ADA and EASD jointly released new medication recommendations for adults with type 2 diabetes. They recommended newer types of diabetes medications as first-line (first recommended) treatment for adults with type 2 diabetes who also have: A heart disease called atherosclerotic cardiovascular disease (ASCVD). Heart failure. Kidney ...
FDA Approves Drug Tirzepatide for Type 2 Diabetes - Healthline
May 13, 2022 · A new drug to treat type 2 diabetes has received approval from federal regulators. The drug tirzepatide is a once-a-week injection that helps people manage blood glucose levels and reduce...
FDA Approves Mounjaro, a Novel Type 2 Diabetes Medication
May 19, 2022 · The Food and Drug Administration (FDA) on May 13 approved Mounjaro (tirzepatide), a new injection treatment for type 2 diabetes. Experts say Mounjaro represents an exciting advancement in diabetes management and it …
Promising new treatment strategy for type 2 diabetes - News …
Oct 14, 2024 · Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for...
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Jun 25, 2021 · Once-weekly injectable semaglutide, a selective GLP-1 receptor agonist, is approved for the treatment of type 2 diabetes at doses up to 1 mg.
FDA Approves Type 2 Diabetes Drug Mounjaro, Which Is ...
The U.S. Food and Drug Administration (FDA) has approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes (T2D), as an addition to diet and...
FDA Approves Mounjaro (Tirzepatide) for Diabetes Treatment
In May 2022, the FDA approved Lilly’s new medication Mounjaro (also known as tirzepatide) for type 2 diabetes management, in addition to diet and exercise. This first-in-class medication has been shown to improve glucose levels and also dramatically improve weight in clinical trials.